Forte Capital LLC ADV Sells 55 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Forte Capital LLC ADV trimmed its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 0.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,639 shares of the medical research company’s stock after selling 55 shares during the period. IQVIA accounts for about 1.1% of Forte Capital LLC ADV’s investment portfolio, making the stock its 27th biggest holding. Forte Capital LLC ADV’s holdings in IQVIA were worth $9,393,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of IQV. Concurrent Investment Advisors LLC boosted its holdings in IQVIA by 5.6% during the third quarter. Concurrent Investment Advisors LLC now owns 5,679 shares of the medical research company’s stock worth $1,346,000 after purchasing an additional 301 shares during the last quarter. Maia Wealth LLC raised its position in shares of IQVIA by 10.5% in the third quarter. Maia Wealth LLC now owns 12,767 shares of the medical research company’s stock valued at $3,025,000 after purchasing an additional 1,213 shares during the period. Hardman Johnston Global Advisors LLC increased its position in IQVIA by 0.6% during the third quarter. Hardman Johnston Global Advisors LLC now owns 229,055 shares of the medical research company’s stock worth $54,279,000 after acquiring an additional 1,360 shares during the period. Marks Group Wealth Management Inc increased its position in IQVIA by 2.0% during the third quarter. Marks Group Wealth Management Inc now owns 34,602 shares of the medical research company’s stock worth $8,200,000 after acquiring an additional 678 shares during the period. Finally, Fiduciary Family Office LLC increased its position in IQVIA by 165.3% during the third quarter. Fiduciary Family Office LLC now owns 5,666 shares of the medical research company’s stock worth $1,343,000 after acquiring an additional 3,530 shares during the period. 89.62% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares of the company’s stock, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on IQV shares. JPMorgan Chase & Co. reduced their price target on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating on the stock in a research note on Tuesday. Truist Financial lowered their price target on shares of IQVIA from $286.00 to $265.00 and set a “buy” rating for the company in a report on Monday. TD Cowen lowered their price target on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a report on Friday, November 1st. The Goldman Sachs Group lowered their price objective on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $270.00 price target on shares of IQVIA in a research note on Friday, November 1st. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $259.13.

IQVIA Stock Up 3.9 %

Shares of IQV opened at $221.19 on Thursday. The firm has a market cap of $40.15 billion, a P/E ratio of 29.03, a P/E/G ratio of 2.15 and a beta of 1.51. IQVIA Holdings Inc. has a 1 year low of $190.20 and a 1 year high of $261.73. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. The stock has a 50 day simple moving average of $232.31 and a two-hundred day simple moving average of $229.48.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.